Suven Pharmaceuticals Limited (BOM:543064)
India
· Delayed Price · Currency is INR 1,225.60
+15.05 (1.24%)
At close: Feb 21, 2025
Suven Pharmaceuticals Revenue
Suven Pharmaceuticals had revenue of 3.07B INR in the quarter ending December 31, 2024, with 39.73% growth. This brings the company's revenue in the last twelve months to 10.48B, down -10.21% year-over-year. In the fiscal year ending March 31, 2024, Suven Pharmaceuticals had annual revenue of 10.51B, down -21.56%.
Revenue (ttm)
10.48B
Revenue Growth
-10.21%
P/S Ratio
n/a
Revenue / Employee
8.79M
Employees
1,193
Market Cap
312.21B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,398.38B |
| Tata Consultancy Services | 2,520.82B |
| HDFC Bank | 2,702.59B |
| Bharti Airtel | 1,627.08B |
| ICICI Bank | 1,755.26B |
| Infosys | 1,635.60B |
| State Bank of India | 3,409.52B |
| Hindustan Unilever | 626.61B |